US Stock MarketDetailed Quotes

ATXS Astria Therapeutics Inc

Watchlist
  • 10.420
  • -0.080-0.76%
Trading Nov 29 09:57 ET
588.04MMarket Cap-4779P/E (TTM)

Astria Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
43.38%29.01M
90.72%28.8M
78.98%24.15M
26.78%67.83M
32.96%19M
63.38%20.24M
31.91%15.1M
-12.26%13.49M
76.23%53.5M
50.29%14.29M
Selling and administrative expenses
23.28%8.5M
34.61%8.09M
54.29%8.42M
33.60%25.7M
56.05%7.33M
47.14%6.9M
24.44%6.01M
8.76%5.46M
29.93%19.24M
23.17%4.7M
-General and administrative expense
23.28%8.5M
34.61%8.09M
54.29%8.42M
33.60%25.7M
56.05%7.33M
47.14%6.9M
24.44%6.01M
8.76%5.46M
29.93%19.24M
23.17%4.7M
Research and development costs
53.77%20.51M
127.85%20.71M
95.77%15.73M
22.95%42.13M
21.65%11.67M
73.27%13.34M
37.36%9.09M
-22.45%8.03M
120.32%34.26M
68.47%9.59M
Operating profit
-43.38%-29.01M
-90.72%-28.8M
-78.98%-24.15M
-26.78%-67.83M
-32.96%-19M
-63.38%-20.24M
-31.91%-15.1M
12.26%-13.49M
-76.23%-53.5M
-50.29%-14.29M
Net non-operating interest income expense
78.75%4.52M
81.81%4.65M
82.72%4.24M
491.71%10.2M
174.75%2.8M
478.26%2.53M
1,094.39%2.56M
4,044.64%2.32M
1,313.11%1.72M
2,984.85%1.02M
Non-operating interest income
78.75%4.52M
81.81%4.65M
82.72%4.24M
491.71%10.2M
174.75%2.8M
478.26%2.53M
1,094.39%2.56M
4,044.64%2.32M
1,313.11%1.72M
2,984.85%1.02M
Other net income (expense)
-105.56%-37K
20.00%-16K
-18.75%-19K
-27,647.27%-15.26M
-169,066.67%-15.21M
62.50%-18K
-33.33%-20K
-1,500.00%-16K
99.97%-55K
156.25%9K
Special income (charges)
----
----
----
---15.2M
----
----
----
----
--0
----
-Less:Other special charges
----
----
----
--15.2M
----
----
----
----
----
----
Other non- operating income (expenses)
-105.56%-37K
20.00%-16K
-18.75%-19K
-12.73%-62K
-188.89%-8K
62.50%-18K
-33.33%-20K
-1,500.00%-16K
5.17%-55K
156.25%9K
Income before tax
-38.40%-24.53M
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.70%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
Income tax
Net income
-38.40%-24.53M
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.70%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
Net income continuous Operations
-38.40%-24.53M
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.70%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
Minority interest income
Net income attributable to the parent company
-38.40%-24.53M
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.70%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.40%-24.53M
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.70%-12.57M
26.99%-11.19M
76.37%-51.83M
-39.74%-13.26M
Basic earnings per share
33.33%-0.42
4.44%-0.43
5.00%-0.38
31.83%-2.42
-30.56%-0.94
27.59%-0.63
47.67%-0.45
66.10%-0.4
85.56%-3.55
-122.29%-0.72
Diluted earnings per share
33.33%-0.42
4.44%-0.43
5.00%-0.38
31.83%-2.42
-30.56%-0.94
27.59%-0.63
47.67%-0.45
66.10%-0.4
85.56%-3.55
-122.29%-0.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 43.38%29.01M90.72%28.8M78.98%24.15M26.78%67.83M32.96%19M63.38%20.24M31.91%15.1M-12.26%13.49M76.23%53.5M50.29%14.29M
Selling and administrative expenses 23.28%8.5M34.61%8.09M54.29%8.42M33.60%25.7M56.05%7.33M47.14%6.9M24.44%6.01M8.76%5.46M29.93%19.24M23.17%4.7M
-General and administrative expense 23.28%8.5M34.61%8.09M54.29%8.42M33.60%25.7M56.05%7.33M47.14%6.9M24.44%6.01M8.76%5.46M29.93%19.24M23.17%4.7M
Research and development costs 53.77%20.51M127.85%20.71M95.77%15.73M22.95%42.13M21.65%11.67M73.27%13.34M37.36%9.09M-22.45%8.03M120.32%34.26M68.47%9.59M
Operating profit -43.38%-29.01M-90.72%-28.8M-78.98%-24.15M-26.78%-67.83M-32.96%-19M-63.38%-20.24M-31.91%-15.1M12.26%-13.49M-76.23%-53.5M-50.29%-14.29M
Net non-operating interest income expense 78.75%4.52M81.81%4.65M82.72%4.24M491.71%10.2M174.75%2.8M478.26%2.53M1,094.39%2.56M4,044.64%2.32M1,313.11%1.72M2,984.85%1.02M
Non-operating interest income 78.75%4.52M81.81%4.65M82.72%4.24M491.71%10.2M174.75%2.8M478.26%2.53M1,094.39%2.56M4,044.64%2.32M1,313.11%1.72M2,984.85%1.02M
Other net income (expense) -105.56%-37K20.00%-16K-18.75%-19K-27,647.27%-15.26M-169,066.67%-15.21M62.50%-18K-33.33%-20K-1,500.00%-16K99.97%-55K156.25%9K
Special income (charges) ---------------15.2M------------------0----
-Less:Other special charges --------------15.2M------------------------
Other non- operating income (expenses) -105.56%-37K20.00%-16K-18.75%-19K-12.73%-62K-188.89%-8K62.50%-18K-33.33%-20K-1,500.00%-16K5.17%-55K156.25%9K
Income before tax -38.40%-24.53M-92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.70%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M
Income tax
Net income -38.40%-24.53M-92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.70%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M
Net income continuous Operations -38.40%-24.53M-92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.70%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M
Minority interest income
Net income attributable to the parent company -38.40%-24.53M-92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.70%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.40%-24.53M-92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.70%-12.57M26.99%-11.19M76.37%-51.83M-39.74%-13.26M
Basic earnings per share 33.33%-0.424.44%-0.435.00%-0.3831.83%-2.42-30.56%-0.9427.59%-0.6347.67%-0.4566.10%-0.485.56%-3.55-122.29%-0.72
Diluted earnings per share 33.33%-0.424.44%-0.435.00%-0.3831.83%-2.42-30.56%-0.9427.59%-0.6347.67%-0.4566.10%-0.485.56%-3.55-122.29%-0.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data